Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Lyndsay Harris und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH.
Abstract (Originalsprache)
The National Institutes of Health–US Food and Drug Administration Joint Leadership Council Next-Generation Sequencing and Radiomics Working Group was formed by the National Institutes of Health–Food and Drug Administration Joint Leadership Council to promote the development and validation of innovative next-generation sequencing tests, radiomic tools, and associated data analysis and interpretation enhanced by artificial intelligence and machine learning technologies. A 2-day workshop was held on September 29-30, 2021, to convene members of the scientific community to discuss how to overcome the “ground truth” gap that has frequently been acknowledged as 1 of the limiting factors impeding high-quality research, development, validation, and regulatory science in these fields. This report provides a summary of the resource gaps identified by the working group and attendees, highlights existing resources and the ways they can potentially be employed to accelerate growth in these fields, and presents opportunities to support next-generation sequencing and radiomic tool development and validation using technologies such as artificial intelligence and machine learning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Office of In Vitro Diagnostics (OHT7), Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
- Office of Cancer Clinical Proteomics Research, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Division of Clinical and Healthcare Research Policy, Office of Science Policy, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Lyndsay Harris, Claire Hildebrandt
Förderung
- NIH
Zitieren
APA
Harris, L., Shankar, L. K., Hildebrandt, C., Rubinstein, W. S., Langlais, K., Rodriguez, H., Berger, A., Freymann, J., Huang, E. P., Williams, P. M., Zenklusen, J. C., Ochs, R., Tezak, Z., & Sahiner, B. (2024). Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae136
Vancouver
Harris L, Shankar LK, Hildebrandt C, Rubinstein WS, Langlais K, Rodriguez H, et al. Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae136
BibTeX
@article{Harris2024,
author = {Harris, Lyndsay and Shankar, Lalitha K and Hildebrandt, Claire and Rubinstein, Wendy S and Langlais, Kristofor and Rodriguez, Henry and Berger, Adam and Freymann, John and Huang, Erich P and Williams, P Mickey and Zenklusen, Jean Claude and Ochs, Robert and Tezak, Zivana and Sahiner, Berkman},
title = {Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae136}
}
EUVIMED